BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kee GJ, Tan RYC, Rehena S, Lee JJX, Zaw MWW, Lian WX, Yeong J, Tan SM, Lim SH, Tan BKT, Yap YS, Dent RA, Wong FY, Lee GE. Human epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: The Singapore experience. World J Clin Oncol 2020; 11(5): 283-293 [PMID: 32728531 DOI: 10.5306/wjco.v11.i5.283]
URL: https://www.wjgnet.com/2218-4333/full/v11/i5/283.htm
Number Citing Articles
1
Pamela Trillo, Josè Sandoval, Dario Trapani, Eleonora Nicolò, Paola Zagami, Federica Giugliano, Paolo Tarantino, Grazia Vivanet, Liliana Ascione, Alex Friedlaender, Angela Esposito, Carmen Criscitiello, Giuseppe Curigliano. Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastasesEuropean Journal of Cancer 2023; 185: 119 doi: 10.1016/j.ejca.2023.02.028
2
Elle N. Clelland, Harriet T. Rothschild, Anne Patterson, Julissa Molina-Vega, Mandeep Kaur, W. Fraser Symmans, Christopher J. Schwartz, A. Jo Chien, Christopher C. Benz, Rita A. Mukhtar. Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomesBreast Cancer Research and Treatment 2023; 202(2): 367 doi: 10.1007/s10549-023-07059-y
3
Mukaddes Yılmaz, Eda Erdiş, Mahmut Uçar, Birsen Yücel. İnvaziv lobüler meme karsinomunun klinik özellikleri ve sağkalim sonuçlarıTurkish Journal of Clinics and Laboratory 2024; 15(2): 190 doi: 10.18663/tjcl.1458189